Introduction
Most women believe that an ultrasound is part of routine prenatal care and they look forward to having an ultrasound image as their first baby photo. Because of their interest in and enjoyment of prenatal ultrasound exams, more than half of women surveyed would be willing to pay additional fees and to go outside their primary care network to obtain a sonogram. 1 Also indicative of the high demand is the inclusion of routine ultrasound in some HMO plans in competitive markets where the fear of losing patients to other plans that offer such screening may override other cost-benefit considerations. 2 In fact, in 60% to 70% of pregnancies, at least one ultrasound is performed. 3 In the year 2000, ultrasound exams were performed in 67% of live births in the United States. 4 In Europe, routine ultrasound is standard practice, and many women receive more than one sonogram. In Israel and some other countries, scans are commonly performed in each trimester of pregnancy. In spite of the common use of ultrasound in industrialized countries, there is a paucity of evidence demonstrating a clear benefit of routine ultrasound in low-risk pregnancy. Thus, the practice of routine ultrasound screening during pregnancy remains the subject of international debate. Much of this debate is driven by the interest of health care payers to contain rising medical costs by limiting access to ultrasound examinations.
Purported Benefits of Routine Ultrasound
The most commonly cited benefits of routine ultrasound screening in the mid trimester include better gestational age assessment, detection of multiple gestations, and the detection of unsuspected fetal anomalies. Since many aspects of obstetrical decision-making are dependent upon the gestational age of the fetus, improved pregnancy dating would seem to be of obvious benefit. Indeed, several such benefits have been demonstrated. For example, it has been shown that routine ultrasound increases the triple screen's detection rate of Down syndrome while lowering the false positive rate. 5 Several randomized studies have shown that there is a reduced incidence of labor induction for post-date pregnancy when "routine" rather than "indicated" ultrasound is used (OR 0.61, CI 0.52,0.72) 6 . Additionally, it would seem obvious that the accurate and early diagnosis of twins would improve outcomes. A Cochran analysis of 6 randomized trials 6 found that multiple gestations were detected earlier with routine scanning, with a lower incidence of undetected twins at 26 weeks (OR 0.08,CI 0.04, 0.16).
In spite of the fact that routine ultrasound has these and other apparent benefits, the RADIUS and other trials have not shown an improvement in the "bottom line" (ie, its use has not resulted in a reduction in perinatal mortality or morbidity). In the RADIUS study, the morbidity rate was 5% in both the "routine ultrasound" group and the control group. 7 Critiques of this study have pointed out that it may be unreasonable to expect a screening test-in this case ultrasound-to alter morbidity in a study for which no interventions were specified. For example, the RADIUS trial showed an improvement in the diagnosis of post-date pregnancy, but morbidity was not altered, perhaps because there was no consistent intervention for this diagnosis.
Until there are studies showing that routine ultrasound enhances the ability of obstetricians to recognize and improve the outcome of pregnancy complications, the most substantial argument in favor of routine ultrasound screening will center on its ability to diagnose birth defects. "Routine" rather than "indicated" ultrasound screening may be necessary to diagnose most birth defects prenatally, since 75% of fetal anomalies occur in women considered to be low risk.
Sensitivity of Ultrasound for the Diagnosis of Birth Defects
Worldwide, there have been several large trials, which have sought to determine the accuracy of routine ultrasound for diagnosing birth defects. The RADIUS study is the largest such study to be performed in the United States. 7 This multicenter trial involved over 15,000 women, selected to be at very low risk for adverse pregnancy outcome, randomized to receive an ultrasound at 16 to 20 weeks and at 31 to 33 weeks or when clinically indicated. Sonograms were performed in both private practices and tertiary centers. This study had disappointing results in terms of diagnosing major anomalies, with only 17% of cases detected prior to 24 weeks in the screened group. Still, this detection rate was three times higher than the 5% detection rate in the control group.
These results contrast sharply with those of the Helsinki trial, a population-based randomized trial that included 95% of the women delivering in the Helsinki metropolitan area. 8 Here, patients were randomly assigned to have a screening ultrasound between 16 and 20 weeks or to have scans only when clinically indicated. Scans were performed by specially trained nurses at one university and one city hospital. The perinatal mortality rate in the screened group of 0.46% was significantly lower than the 0.9% rate in controls, due principally to induced abortions when anomalies were detected. The detection rate for fetal anomalies was 45%-over two and one-half times higher than the detection rate in the RADIUS trial.
The Eurofetus study stands as the largest study designed to evaluate routine ultrasound screening for detection of fetal anomalies. 9 Over 200,000 women were scanned in 14 European countries in 60 hospital ultrasound units. The sensitivity for detection of fetal anomalies in this study was 64%. Almost 4000 malformed fetuses were identified, providing an enormous database with significant statistical power to reach meaningful conclusions. For comparison, the RADIUS study identified 182 anomalous fetuses.
Factors Affecting Sensitivity
The range of sensitivities for detection of fetal anomalies reported in these and other large studies varies between 23% and 64%. [6] [7] [9] [10] [11] [12] [13] Since adequate sensitivity is a key issue in determining the cost-benefit balance of routine ultrasound, it is important understand why there has been such a broad
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range of sensitivities reported. A number of factors affect detection rates, including the prevalence of birth defects in the population studied, the gestational ages at which exams are performed, the method of defining and ascertaining anomalies, the distribution of anomalies by organ system, and the practice setting and personnel performing the studies.
Risk Category
The prevalence of a disease in a population is generally thought to influence the positive predictive value but not the sensitivity of a screening test. However, in both research and general clinical settings, it is likely that not all screening ultrasound exams are conducted with exactly the same care. In spite of a nominally standardized approach to the examination, it is likely that more time and attention will be devoted to scans in patients who are thought to be high risk. For this reason, a screening examination may be more sensitive in a high-risk population and, thus, the prevalence of anomalies in a population studied may have a major impact on the detection rate. The low detection rate in the RADIUS trial may be partly explained by the fact that this study specifically excluded all but the lowest-risk patients. The Helsinki trial and the Eurofetus study, on the other hand, were cross-sectional studies, which included a spectrum of both low-and higher-risk patients. The effect of study population on the sensitivity of screening ultrasound was evaluated in a review of 36 studies published between 1983 and 1999.
14 The sensitivity was higher in studies from single hospitals (which tended to include a higher proportion of high-risk women) than those that included a spectrum of practice types, and the average sensitivity from regular-risk samples was 55% compared with 92% in high-risk populations. Therefore, the distribution of low-and high-risk women in any study must be taken into account when evaluating a study's reported malformation detection rate.
Value of Repeated Screening
When evaluating the sensitivity of a study, it is important to consider the gestational age at screening and the number of scans performed per patient. Some abnormalities, such as congenital diaphragmatic hernia and cardiac abnormalities, may be more apparent at later gestational ages. It is not surprising that the RADIUS study demonstrated that the addition of a third trimester scan increased the number of anomalies detected. In Levi's review of 36 studies, he found that the average sensitivity using one scan before 20 weeks was 45% compared with 60% when more than one scan was performed.
14

Definition and Ascertainment of Anomalies
The overall prevalence of fetal abnormalities may have also impacted the reported sensitivity in the RADIUS study. The prevalence of 2.4% is much higher than the median prevalence of 1.7% in the 36 studies reviewed by Levi. 14 This is probably attributable to more comprehensive postnatal ascertainment and broadly inclusive definitions of abnormalities in the RADIUS trial. Postnatal evaluations that play a role in ascertainment include routine autopsy, a thorough neonatal examination, and routine imaging studies. The length of the followup period also can significantly affect the calculated sensitivity of prenatal ultrasound, since some anomalies may not become apparent for months or even years after birth. While the prevalence of anomalies of 2.2% in the Eurofetus study appears similar to that of the RADIUS trial, it should be noted that this prevalence does not include abnormalities considered minor or difficult to visualize. In an effort to compare studies on more similar terms, Levi compared sensitivities using a fixed prevalence rate of 2%. 14 In this
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Raynor analysis, the standardized sensitivity of the RADIUS study increased to 43% and of the Eurofetus study to 69%.
Spectrum of Anomalies
The spectrum and definition of malformations can also influence the apparent sensitivity of ultrasound for detecting birth defects. Central nervous system abnormalities are more easily detected than skeletal or cardiac anomalies. In several series, over 90% of central nervous system abnormalities were detected. 7, 12, 15 The detection rate for cardiac abnormalities ranged in these studies from 28% to 43%, while 69% to 100% of urinary tract disorders and about 30% of craniofacial anomalies were detected. A high prevalence of central nervous system abnormalities vis a vis the other types of malformations will elevate the reported detection rate in a study. For example, in an early study in which anomalies involved the central nervous system in 52% of cases, the overall sensitivity was 82%. 16 
Expertise of Sonographers
One factor that has not yet been adequately considered is the effect of operator expertise on the diagnostic accuracy of ultrasound. The RADIUS trial was one of the few trials to include scans performed by both general practices and hospital units, allowing comparisons between the two settings. In spite of extensive quality control measures at all study sites, the detection rate in "practicebased" centers was only 13%, compared with a rate of 35% in the tertiary units. Crane speculated that the low detection rate in the community settings resulted from inexperience and the relatively low numbers of birth defects to which sonographers in these settings are exposed. 17 In the Eurofetus study, all sonograms were performed in nontertiary hospital-based units and did not include smaller practice settings. 9 The authors of this study suggested that the improved ultrasound equipment and uniform training for ultrasound providers contributed to the good overall sensitivity in this trial.
These publications provide some idea of the importance of the type of facility and patient volume at a given center, but do not evaluate the expertise of individual sonographers within centers. 10, 17 Only a few studies have tried to address the accuracy of individual physicians' diagnoses. One study evaluated the diagnostic agreement between perinatologists and radiologists participating in the California AFP program. 18 These physicians worked in both private practices and academic institutions and were required to perform at least 200 scans annually to remain certified to participate in the program. They reviewed selected images from 15 cases and their interpretations were evaluated. There was moderate to substantial agreement between the 148 physicians for major abnormalities as well as ultrasound markers of chromosomal abnormalities. The highest consistency occurred when the images involved the central nervous system, face, and neck. There was no difference in interpretation between perinatologists and radiologists or between physicians in academic and private practices. The sensitivity for detection ranged from 60% for renal abnormalities to 91% for central nervous system abnormalities with false-positive rates of 7% and 9%, respectively. Physicians with the highest accuracy had the highest falsepositive rates. The authors found the magnitude of agreement for diagnosis of fetal anomalies as well as for aneuploidy markers was similar to that of other diagnostic imaging tests, such as screening mammography. This investigation supports the notion that well-trained practitioners with high-volume practices consistently interpret ultrasound examinations similarly.
Diagnostic Limitations
Because of the limitations in sensitivity for prenatal ultrasound described above, no patient can be definitively assured that her baby is normal. In reality, a normal sono-
Routine Ultrasound in Pregnancy
gram may lower the likelihood of anomalous child by as little as 17%. 19 Even in the most experienced hands, the likelihood of abnormality is reduced by about 50%; not the level of certainty most patients presume. 9 Further, several studies have shown a 5% to 10% possibility that a normal fetus will be falsely identified as abnormal. Anderson et al found that while 93 of 157 anomalies were correctly identified by ultrasound before 20 weeks, 10 fetuses diagnosed with abnormalities were normal on postnatal examination at 1 month. 12 SmithBindman reviewed several screening studies and found that 1% to 10% of normal fetuses were incorrectly thought to be abnormal by the screening sonographer and that physicians with the highest accuracy had the highest false-positive rates. 18 In the Eurofetus study, 9.9% of diagnosed abnormalities were false positives and 6% of screened patients had "false alarms" (ie, fetuses initially thought to have anomalies were found to be normal on subsequent scans).
9
Effects of Routine Screening on Outcomes in Fetuses With Anomalies
The Helsinki trial demonstrated a decrease in the overall perinatal mortality rate in the patients who had a routine ultrasound, primarily because of induced abortions of fetuses with serious anomalies. 20 Eleven of 12 fetuses with malformations were terminated, compared with no abortions for malformations in the control group. In contrast, the RADIUS trial demonstrated no decrease in perinatal mortality in the routine ultrasound group. The difference may be due to the fact that, in this study, only 5% of women in whom anomalies were detected prior to 24 weeks chose abortion. In the RADIUS cases in which pregnancy termination was chosen, half of the fetuses had lethal anomalies and the remainder had defects that would have been severely disabling.
There is emerging evidence that prenatal diagnosis of anomalies by routine ultrasound results in better neonatal outcomes for fetuses that are not aborted. Anderson et al reviewed several studies published between 1990 and 1995 to evaluate detection rates and outcomes in over 86,000 pregnancies with 1254 anomalies. 12 To improve comparisons, the authors used a standardized list of anomalies from the other studies for inclusion in their analysis. Adverse outcomes, including death but excluding voluntary termination, were significantly lower in anomalous fetuses detected by ultrasound compared with those not detected (P value <0.001 level in all studies except the RADIUS study). Unfortunately, comparison of specific outcomes between studies was difficult because definitions of adverse outcomes varied widely between studies, ranging from NICU admission to the surgical severity of malformations.
Since most studies have evaluated neonatal outcomes only, the impact of routine ultrasound on long-term childhood morbidity, particularly in defects where early detection can prevent chronic damage, has not been adequately addressed. For instance, the prenatal diagnosis of pyelectasis can provide early identification of neonates with renal dysfunction eventually requiring surgery. 19 Midtrimester detailed sonography has improved the detection of urinary tract abnormalities fivefold, which has made possible referral for early evaluation and treatment. 21 
Ascertainment of Other Conditions
One important benefit of routine ultrasound screening is that an abnormal scan may prompt additional prenatal diagnostic testing. Identification of a structural abnormality is often an indication for performing a fetal karyotype. Consequently, routine ultrasound has been shown to increase in the ascertainment of infants with chromosomal anomalies by 10%.
14 Similarly, other ultrasound markers may prompt evaluation for perinatal infections. Targeted ultrasound
886
Raynor performed after a screening ultrasound uncovers one anomaly may disclose additional defects. For example, Grandjean et al found an average of 1.25 malformations per fetus referred because of an anomaly suspected on a screening ultrasound. 9 In another study, 80% of cases with a clubfoot had additional defects identified.
14 When a fetus with serious anomalies is stillborn or dies soon after birth without prenatal referral to a tertiary center, genetic evaluation often remains incomplete. The lack of a firm diagnosis in an index pregnancy with a lethal outcome often precludes accurate genetic counseling in a future pregnancy.
Cost-Benefit Analysis of Screening
The cost-effectiveness of routine ultrasound screening remains controversial. Few analyses have addressed this issue in a sophisticated manner. Besides the costs of screening, important factors which must be taken into account include the complexity of medical decision-making, the range of anomalies which can be diagnosed and prognosis associated with each, the wide range of reported sensitivities for sonographic identification of abnormalities, the varying attitude of different populations regarding pregnancy termination, and the cost for care of anomalous fetuses. Early attempts to analyze cost-benefit of routine ultrasound based on the RADIUS study concluded that cost-benefit accrued when the diagnostic accuracy was similar to the tertiary centers, but not in the primary centers 22 and, similarly, that with the higher ultrasound detection rates, the cost per diagnosed case is less than the cost using MSAFP screening. 23 Roberts concluded that the lack of quality evidence and the range of uncertainty prevented him from drawing conclusions about the cost-effectiveness of ultrasound screening. 24, 25 Waitzman and Romano employed a complex model using multiple factors including the sensitivity of detection, maternal response to the information, cost of newborn care, number of ultrasounds, voluntary termination of pregnancy, and "replacement cost" for terminated fetuses. 26 They then created multiple scenarios for combinations of the high and low estimates for several factors. The authors concluded that the most likely estimate of benefit-to-cost, 1.73, does not favor routine ultrasound screening. However, in a corollary decision analysis, the same authors found that the expected utility for routine ultrasound to detect anomalies in the second trimester was clinically significant if the sensitivity and specificity of the sonogram remains high.
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Conclusions
Clearly the efficacy of routine ultrasound is strongly dependent on the competence and training of personnel and the sensitivity of diagnosis. Ultrasound technology continues to advance. The introduction of threedimensional imaging as well as the development of new markers should help improve diagnostic accuracy. Standardization of training and efforts to establish certification programs should help upgrade the quality of sonography performed at all sites.
Routine ultrasound screening does appear to reduce adverse outcomes in fetuses diagnosed with congenital anomalies. The lack of good quality analyses of cost-benefit prevent a clear conclusion, but the most sophisticated analyses suggest that the costbenefit of routine screening ultrasound is dependent on the sensitivity of detection, the cost of ultrasound examinations, and the rate of pregnancy termination.
There are other concerns beyond cost. Chervenak has suggested that the omission of an offer to provide ultrasound screening during pregnancy violates patient autonomy by denying information for management decision making. 27 He argues that the physician should have an "informed consent" discussion of the actual and theoretical benefits and harm from ultrasound with each patient and give her an opportunity to express her preference for an ultrasound examination.
